TG Therapeutics Inc (TGTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

2 GANSEVOORT STREET, 9TH FLOOR NEW YORK, NY 10014

Data as of 2021-02-27 10:35:10 -0500
Market Cap5.755 Billion Shares Outstanding131.49 Million Avg 30-day Volume1.46 Million
P/E Ratio-24.94345 Dividend Yield EPS-2.13
Price/Sales37863.99 Debt to Equity1.6 EBITDA-224.643 Million
Price to Book Value33.72 Forward PE-21.56 Enterprise Value5.531 Billion
Total Cash254.154 Million Current Debt77.67 Million Gross Profit152 Thousand
BETA1.51905 52-week High/Low56.74 / 6.34 Price to Cash FLow (P/CF) -9999999.0
Data provided by IEX Cloud
View SEC Filings from TGTX instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 10 5 100.0% 10 (0.6%) 5 (0.31%) 100.0%
Funds Holding: 245 180 36.11% 91 (5.49%) 63 (3.92%) 44.44%
13F shares: 98.741 Million 86.423 Million 14.25% 38.877 Million 38.407 Million 1.22%
% Ownership 71.6501 65.7255 9.01% 28.2105 29.2091 -3.42%
New Positions: 82 32 156.25% 33 11 200.0%
Increased Positions 77 73 5.48% 24 21 14.29%
Closed Positions 14 24 -41.67% 6 11 -45.45%
Reduced Positions 56 50 12.0% 25 23 8.7%
Total Calls 2.562 Million 1.756 Million 45.89% 656.5 Thousand 315.8 Thousand 107.88%
Total Puts 1.953 Million 1.404 Million 39.1% 487.913 Thousand 354 Thousand 37.83%
PUT/CALL Ratio 0.76 0.8 -5.0% 0.74 1.12 -33.93%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding TGTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding TGTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

WEISS MICHAEL S CEO AND PRESIDENT

  • Officer
  • Director
13,068,082 2020-12-31 1

POWER SEAN A CFO, SECRETARY AND TREASURER

  • Officer
629,438 2020-12-31 2

ECHELARD YANN

  • Director
129,116 2020-12-10 1

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
TG THERAPEUTICS INC TGTX 2021-03-02 12:45:03 UTC -0.18 0.25 1100000
TG THERAPEUTICS INC TGTX 2021-03-01 22:15:04 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 21:45:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 21:15:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 20:45:02 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 20:15:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 19:45:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 19:15:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 18:45:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 18:15:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 17:45:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 17:15:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 16:45:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 16:15:02 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 15:45:03 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 15:15:02 UTC -0.18 0.25 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 14:45:03 UTC -0.1906 0.2606 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 14:15:03 UTC -0.1906 0.2606 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 13:45:03 UTC -0.1906 0.2606 1300000
TG THERAPEUTICS INC TGTX 2021-03-01 13:15:03 UTC -0.1906 0.2606 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
Trust for Professional Managers- Convergence Long/Short Equity Fund TGTX -1512.0 shares, $-44362.08 2020-11-30 N-PORT
LoCorr Investment Trust- LoCorr Dynamic Equity Fund TGTX -458.0 shares, $-23825.16 2020-12-31 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund TGTX -679.0 shares, $-35321.58 2020-12-31 N-PORT
FundVantage Trust- Gotham Master Neutral Fund TGTX -1.0 shares, $-26.76 2020-09-30 N-PORT
Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund TGTX -13100.0 shares, $-681462.0 2020-12-31 N-PORT

Elevate your investments